Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences 3D-Culture, Organoids and Organs-on-Chips 2021

3D-Culture, Organoids and Organs-on-Chips 2021

Date: Monday, 22 March 2021 - Tuesday, 23 March 2021


Conference Chair

Terry Riss

Terry Riss
Global Strategic Marketing Manager Cell Health, Promega Corporation

Keynote Speakers

Thomas Hartung

Thomas Hartung
Professor and Doerenkamp-Zbinden Chair for Evidence-based Toxicology, Director of the Center for Alternatives to Animal Testing (CAAT), Johns Hopkins Bloomberg School of Public Health

Linda Griffith

Linda Griffith
Professor, Massachusetts Institute of Technology (MIT)

Nancy Allbritton

Nancy Allbritton
Frank and Julie Jungers Dean of the College of Engineering and Professor of Bioengineering, University of Washington in Seattle

Roger Kamm

Roger Kamm
Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT)

Josué  Sznitman

Josué Sznitman
Associate Professor, Technion – Israel Institute of Technology

Kevin Healy

Kevin Healy
Jan Fandrianto and Selfia Halim Distinguished Professorship in Engineering, University of California, Berkeley

John Wikswo

John Wikswo
Gordon A. Cain University Professor, A.B. Learned Professor of Living State Physics; Founding Director, Vanderbilt Institute for Integrative Biosystems, Vanderbilt University

Michael Shuler

Michael Shuler
Samuel B. Eckert Professor of Engineering, Cornell University, President Hesperos, Inc.

Overview

Welcome to the SelectBIO 3D-Culture, Organoids & Organs-on-Chips 2021 Conference to be held March 22-23, 2021.The time zone anchor of this conference is the US Eastern Time Zone.

This conference brings together the innovations in 3D-Culture, Organoids and Organs-on-Chips, circa 2021 and bring the key opinion leaders and thought leaders in the field from around the world for two intensive days of scientific presentations, networking as well as engagement with companies developing innovations in tools and technologies in this expanding space.

These fields are fast-moving spaces with extreme levels of innovation currently.  The goal of this conference is to provide a snapshot of this field and describe the technologies and applications driving this space forward.  The conference features scientific presentations, technology spotlight presentations, and companies in the space as well as exhibits which feature the latest products and service offerings to the field.

Agenda Topics

  • 3D Culture to Organoid to Organ-on-a-Chip Continuum
  • Case Studies using Organoids in Research, High Throughput Screening and Personalized Medicine
  • Converting from 2D to 3D Culture Models
  • Development and use of Advanced Microfluidic Chip Devices for Studying Organoids
  • Emerging Technologies for Reproducible Production of Organoids
  • High Content Imaging and Phenotypic Assays of 3D-Culture Models and Organoids
  • Microtissues
  • Modeling Diseases-on-a-Chip
  • Organ-on-a-Chip Applications for Drug Discovery
  • Organoid Models for Studying Infectious Diseases
  • Organoids-on-a-Chip
  • Spheroids -- 3D Aggregates of Cells in Culture
  • Technologies in the Organs-on-Chips Field
  • Tumor Organoids and Spheroids

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Confirmed Speakers to date

Evan Cromwell, President & CEO, Protein Fluidics
Anthony Davies, Adjunct Assistant Professor, Trinity College Dublin
Albert Folch, Professor of Bioengineering, University of Washington
James Hickman, Professor, Nanoscience Technology, Chemistry, Biomolecular Science and Electrical Engineering, University of Central Florida; Chief Scientist, Hesperos
Yuichi Hikichi, General Manager, MDB Division , Yamaha Motor
Min Jae Song , Staff Scientist, National Center for Advancing Translational Sciences (NCATS)
MoonSun Jung, Senior Research Officer, Children’s Cancer Institute Australia
Jirina Kroupová, Researcher, University of Chemistry and Technology, Prague
Oksana Sirenko, Sr. Imaging Applications Scientist, Molecular Devices
Glauco Souza, Director of Global Business Development and Innovation, 3D Cell Culture at Greiner Bio-One; Adjunct Assistant Professor, Greiner Bio-One and University of Texas Health Science Center at Houston


Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Add to Calendar ▼2021-03-22 00:00:002021-03-23 00:00:00Europe/London3D-Culture, Organoids and Organs-on-Chips 20213D-Culture, Organoids and Organs-on-Chips 2021 in SELECTBIOenquiries@selectbiosciences.com